Reducing antibiotic use in influenza: challenges and rewards

Area of Science:

• Infectious Diseases
• Microbiology
• Public Health

Background:

• Respiratory tract infections (RTIs) are common, with viral infections frequently leading to antibiotic prescriptions.
• Bacterial complications of viral RTIs, like pneumonia, drive significant antibiotic consumption.
• Widespread antibiotic use for RTIs contributes to the growing problem of antimicrobial resistance.

Purpose of the Study:

• To highlight the link between viral RTIs, particularly influenza, and inappropriate antibiotic prescribing.
• To advocate for improved diagnosis and treatment strategies for viral respiratory infections.
• To emphasize the role of antivirals in reducing antibiotic use and resistance.

Main Methods:

• Review of current literature on RTI etiology, antibiotic prescribing patterns, and antimicrobial resistance.
• Analysis of the impact of influenza on secondary bacterial infections and antibiotic use.
• Evaluation of diagnostic tools (e.g., RT-PCR) and antiviral therapies (e.g., neuraminidase inhibitors).

Main Results:

• A significant proportion of patients with influenza-like illness receive antibiotics, often unnecessarily.
• Antiviral treatments for influenza are effective in preventing complications and reducing antibiotic consumption.
• Viral resistance to neuraminidase inhibitors is low, and they lack cross-resistance with antibiotics.

Conclusions:

• More accurate diagnosis of viral infections, especially influenza, is crucial.
• Implementing antiviral therapies can decrease antibiotic use and mitigate resistance.
• Adopting these strategies can significantly impact antimicrobial stewardship and public health outcomes.